首页|缝隙介导干细胞治疗缺血性卒中的研究进展

缝隙介导干细胞治疗缺血性卒中的研究进展

扫码查看
缺血性卒中仍是当今世界主要的死亡原因之一.传统的治疗方法存在时间窗狭窄的问题,且治疗后卒中幸存者往往存在神经功能缺损症状.干细胞疗法可以通过增强大脑可塑性来减少神经系统后遗症,而缝隙连接在脑发育过程中对细胞的增殖、迁移和分化是必不可少的,利用小分子(如葡萄糖)通过缝隙连接在干细胞与血管内皮细胞之间的转移构成了干细胞治疗缺血性卒中的重要机制.本文干细胞疗法通过缝隙连接介导治疗缺血性卒中的研究进展进行综述,主要总结了间充质干细胞、造血干细胞、神经干细胞与胚胎干细胞的细胞来源、作用机制以及研究成果,以便深入挖掘干细胞疗法治疗卒中的新思路,以期为临床治疗提供辅助.
Research progress on gap junction-mediated stem cell therapy for ischemic stroke
Ischemic stroke is still one of the main causes of death in the world today.Conventional therapeutic strategies are limited by the narrow time window,and survivors often have neurological deficits after treatment.Stem cell therapy can reduce neurological sequelae by enhancing brain plasticity,while gap junctions are essential for cell proliferation,migration and differentiation during brain development.The transfer of small molecules(e.g.,glucose)between stem cells and vascular endothelial cells through gap junctions constitute an important mechanism of stem cell therapy for ischemic stroke.In this article,we review the research progress of stem cell therapy for ischemic stroke through gap junctions.We mainly summarize the cell source,mechanism of action and research results of mesenchymal stem cells,hematopoietic stem cells,neural stem cells and embryonic stem cells in stem cell therapy for ischemic stroke,so as to explore new ideas of stem cell therapy for ischemic stroke and to provide assistance for clinical treatment.

stem cell therapygap junction mediationischemic strokeresearch progressreview

杨艾琳、刘长兴、王金仙、郑艳、常翔

展开 >

712046 陕西省咸阳市,陕西中医药大学

陕西省西安市中医医院

干细胞疗法 缝隙连接介导 缺血性卒中 研究进展 综述

国家中医药管理局第六批全国老中医药专家学术继承工作室

国中医药人教发[2017]29号

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(3)
  • 59